Drug Detail:Eysuvis (Loteprednol etabonate)
Drug Class: Ophthalmic steroids
Loteprednol Levels and Effects while Breastfeeding
Summary of Use during Lactation
No information is available on the ophthalmic use of loteprednol during breastfeeding. Because absorption from the eye is limited, ophthalmic loteprednol would not be expected to cause any adverse effects in breastfed infants. To substantially diminish the amount of drug that reaches the breastmilk after using eye drops, place pressure over the tear duct by the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Prednisolone
Substance Identification
Substance Name
Loteprednol
CAS Registry Number
129260-79-3
Drug Class
-
Breast Feeding
-
Lactation
-
Anti-Inflammatory Agents
-
Corticosteroids, Ophthalmic
-
Glucocorticoids
-
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- Drug Levels and Effects
- Substance Identification